Phase 1/2 study of DFP‐10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia-Reference-Cited by-同舟云学术

Phase 1/2 study of DFP‐10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia

Published:2019-01-22 Issue:10 Volume:125 Page:1665-1673
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kantarjian Hagop M.¹,Jabbour Elias J.¹^ORCID,Garcia‐Manero Guillermo¹^ORCID,Kadia Tapan M.¹^ORCID,DiNardo Courtney D.¹^ORCID,Daver Naval G.¹^ORCID,Borthakur Gautam¹,Jain Nitin¹,Waukau Jane B.¹,Kwari Monica I.¹,Ravandi Farhad¹,Anderson Barry D.²,Iizuka Kenzo³,Jin Cheng³,Zhang Chun³,Plunkett William K.⁴

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

2. Theradex Oncology PrincetonNew Jersey

3. Delta‐Fly Pharma Inc Tokushima Japan

4. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas

Funder

Delta-Fly Pharma Inc

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31923

Reference9 articles.

1. New drugs in acute myeloid leukemia

2. Analysis of the prolonged infusion of DFP‐10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo;Iizuka K;Int J Oncol,2018

3. Optimal two-stage designs for phase II clinical trials

4. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

5. Nonparametric Estimation from Incomplete Observations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrest;European Journal of Pharmacology;2023-07

2. Hsp70, in Combination with IL-15 and PD-1 Blocker, Interferes with The Induction of Cytotoxic NK Cells in Relapsed Acute Myeloid Leukemia Patients;CELL J;2023

3. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells;Journal of Experimental & Clinical Cancer Research;2021-10-12

4. Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells;2021-07-20

5. CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death;Molecular Cancer Therapeutics;2019-09-09